Lactic acid, once considered a byproduct of glycolysis, has now emerged as a crucial player in the interaction between tumors and the immune system. Over time, research has unveiled various roles of lactic acid in pH regulation, signaling through G-protein-coupled receptors, post-translational modifications, and metabolic shuttling within and between cells. In the tumor microenvironment, high glycolytic activity leads to the export of lactate and protons, causing extracellular acidity that hinders drug efficacy and promotes cancer cell survival by enhancing genomic stability and chemoresistance. Moreover, lactate metabolism influences immune responses by modulating the functions of various immune cell populations.
Tumor-associated macrophages undergo reprogramming in response to lactate, promoting a phenotype that supports metastasis. Dendritic cells and natural killer cells also experience functional impairments due to lactate-induced acidification, leading to reduced antigen presentation and compromised immune surveillance. Additionally, regulatory T cells utilize lactate to enhance their suppressive functions, while CD8+ T cells face metabolic challenges that affect their effector functions within the tumor microenvironment. Lactate’s impact on immune cells underscores its significance in shaping antitumor immune responses.
Beyond immune cells, stromal components like cancer-associated fibroblasts and endothelial cells further contribute to the immunosuppressive environment by responding to lactate signaling. These interactions highlight the intricate web of lactate-mediated immunosuppression within the tumor microenvironment. To counter these effects, therapeutic strategies are being explored, focusing on glycolytic inhibition, immune modulation, and metabolic repurposing. These approaches aim to disrupt lactate-driven immune evasion and enhance antitumor immunity by targeting lactate metabolism directly or indirectly.
Challenges persist in translating these findings into effective clinical interventions, including potential toxicities of lactate-targeting agents and the complexities of tumor metabolic heterogeneity. Future research directions involve developing innovative drug delivery systems responsive to lactate levels, unraveling lactate-handling pathways at the single-cell level, and validating novel metabolic interventions in clinical settings. By recognizing lactate as a key regulator of immune responses in cancer, researchers are paving the way for innovative cancer immunotherapy strategies that exploit the metabolic vulnerabilities of tumors.
Key Takeaways:
– Lactate metabolism plays a pivotal role in shaping the tumor microenvironment and modulating immune responses in cancer.
– Targeting lactate metabolism offers potential therapeutic avenues to disrupt immune evasion mechanisms and enhance antitumor immunity.
– Challenges in translating lactate-targeting strategies into clinical applications include toxicity concerns and tumor metabolic heterogeneity.
– Future research aims to develop precision interventions that leverage lactate as a druggable immune checkpoint to advance cancer immunotherapy.
Tags: secretion
Read more on news-medical.net